[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
June 4, 2003

States Combat AHPs

JAMA. 2003;289(21):2787. doi:10.1001/jama.289.21.2787-a

The US Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have warned 52 Web sites to discontinue severe acute respiratory syndrome (SARS)–related claims. Internet searches by the two agencies yielded a trove of products advertised to treat or prevent SARS, including air purifiers, disinfectants, masks, latex gloves, and oregano oil. Each site could face fines of $11 000 per violation and seizure of any drugs not approved by the FDA.

"Bogus products from questionable Web sites do no good, and can actually make matters worse by providing a false sense of protection," said FDA Commissioner Mark McClellan, MD, PhD, in a press statement.

First Page Preview View Large
First page PDF preview
First page PDF preview